December 14, 2017

728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads

Global Pharmaceutical Drug Development Services Procurement Market Report 2017 – Top Suppliers are IQVIA, LabCorp, PAREXEL, ICON & INC Research

THIS POST WAS ORIGINALLY PUBLISHED ON THIS SITE Click Here To Read Entire Article

Global Pharmaceutical Drug Development Services Market, provides up-to-date information about market shifts and potential risks, as well as in-depth knowledge of products and services, which can help in planning and in executing category management activities. It focuses on the cost-saving aspects of procurement and on providing insights that can lead to optimization of category spend.

The demand for drug development services comes from pharmaceutical and biotechnology companies. This is mainly because these companies are increasingly outsourcing drug development services to CROs to reduce drug development cost. Additionally, lead identification, drug discovery, clinical trial monitoring, and regulatory compliance are the services that will drive the growth of the global pharmaceutical drug development services market.

One of the procurement best practices for buyers in the global pharmaceutical drug development services market is to collaborate with local CROs if project size is small. There is a trend of long-term strategic partnerships in the industry, and as a result, global CROs allocate their best resources to these strategic alliances.

According to the report, one of the key growth drivers for the global pharmaceutical drug development services market is the high demand for drug development services from pharmaceutical and biotechnology companies. This is mainly because these companies are increasingly outsourcing drug development services to CROs to reduce drug development costs amid increasing regulatory stringency and reimbursements.

Further, the report states that one of the key procurement challenges faced by buyers is the issues in data integration and management. Data integration is a pressing issue for buyers as CROs often use disparate sources and formats that might not be compatible with their systems.

Key Topics Covered:

PART 1: CATEGORY AT A GLANCE

PART 2: SCOPE OF THE REPORT

PART 3: MARKET INSIGHTS

Category Spend Analysis Category Maturity by Regions Demand-Supply Shifts Regional Demand-Supply Snapshot Global Molasses Production Hubs Market Developments Regional Impact of Trends Key Category Growth Drivers and Corresponding Regional Impacts Major Category Growth Constraints and Corresponding Regional Impacts Key Current Technological Innovations Major Regulatory Frameworks Strategic Sustainability Practices Porter’s Five Forces PESTLE Analysis

PART 4: SUPPLY MARKET INSIGHTS

Supplier Operational Capability Matrix Other Prominent Suppliers by Region: Operational Capability Matrix Supplier Functional Capability Matrix Other Prominent Suppliers by Region: Functional Capability Matrix Key Clients/Partners Supplier Cost Breakup Supplier Positioning Matrix

PART 5: PRICING INSIGHTS

Pricing Models Snapshot Pricing Models – Pros and Cons Indicative Pricing

PART 6: PROCUREMENT INSIGHTS

Major Category Requirements Major Procurement Pain

About The Author

Related posts

Leave a Reply

Your email address will not be published. Required fields are marked *

%d bloggers like this: